NCT04428151 · Interventional trial
Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)
Overall registry status Terminated
Phase 2
Conditions Squamous Cell Carcinoma of Head and Neck
Delaware Valley sites
- Fox Chase Cancer Center ( Site 1502) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory